GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alkermes, Inc. (ALKS) [hlAlert]

Rating:
Neutral ALKS
up 19.76 %

Alkermes, Inc. (ALKS) downgraded to Neutral with price target $42 by UBS

Posted on: Thursday,  Dec 5, 2013  12:25 PM ET by UBS

UBS rated Neutral Alkermes, Inc. (NASDAQ: ALKS) on 12/05/2013. Previously UBS rated Buy Alkermes, Inc. (NASDAQ: ALKS) on 05/24/2013., when
the stock price was $33.35. Since then, Alkermes, Inc. has gained 19.76% as of 12/05/2013's recent price of $39.94.
If you would have followed the previous UBS's recommendation on ALKS, you would have gained 19.76% of your investment in 195 days.

Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/28/2014 11:25 AM Hold
None
51.18 53.00
as of 12/13/2013
1 Week   
1 Month up  6.36 %
3 Months up  16.51 %
1 YTD up  115.65 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/5/2013 12:25 PM Hold
None
39.94 42.00
5/24/2013 10:25 AM Buy
None
33.35 37.00
8/23/2011 11:25 AM Buy
None
14.88 21.00
7/8/2011 11:25 AM Hold
None
19.46 20.50
6/7/2011 10:25 AM Hold
None
18.01 19.00
5/10/2011 11:25 AM Hold
None
15.27 16.50
9/30/2010 10:25 AM Buy
None
14.59 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy